ARCHIVES

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

Also Lance Armstrong visits NIH, Washington, for Tour of Hope event.

October 17, 2003

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

November 1, 1985